Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study | |
Zhang, Di; Zhang, Chufeng; Huang, Jiaqi; Guan, Yan; Guo, Qisen | |
刊名 | THORACIC CANCER
![]() |
2018 | |
卷号 | 9期号:12页码:1754-1762 |
关键词 | Angiogenesis inhibitor apatinib advanced non-small-cell lung cancer |
DOI | 10.1111/1759-7714.12898 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4571125 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Shandong Canc Hosp, Dept Oncol, Jinan, Shandong, Peoples R China. 2.[Zhang, Di 3.Zhang, Chufeng 4.Huang, Jiaqi |
推荐引用方式 GB/T 7714 | Zhang, Di,Zhang, Chufeng,Huang, Jiaqi,et al. Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study[J]. THORACIC CANCER,2018,9(12):1754-1762. |
APA | Zhang, Di,Zhang, Chufeng,Huang, Jiaqi,Guan, Yan,&Guo, Qisen.(2018).Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.THORACIC CANCER,9(12),1754-1762. |
MLA | Zhang, Di,et al."Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study".THORACIC CANCER 9.12(2018):1754-1762. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论